98%
921
2 minutes
20
This report describes a 56-year-old female diagnosed with lymphoepithelioma-like carcinoma with carcinosarcoma of the endometrium (LELCCSE). She experienced vaginal bleeding and lower abdominal discomfort without any obvious cause following six years of menopause. She sought treatment at our hospital in Hangzhou, China. An ultrasound examination revealed a hypoechoic mass within the uterus. Subsequently, a biopsy confirmed it as lymphoepithelioma-like carcinoma (LELC) with carcinosarcoma.The patient underwent a total hysterectomy, bilateral salpingo-oophorectomy, and associated lymphadenectomy. The postoperative pathology suggested LELC complicated with carcinosarcoma and an IIC grade by the 2023 FIGO staging system. She received adjuvant chemotherapy and radiotherapy without any molecular testing due to her financial constraints. A gene which encodes the catalytic subunit of DNA polymerase epsilon(POLE) mutation was found by the retrospective molecular testing; however, no recurrence or metastasis occurred after 12 follow-up months.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12318957 | PMC |
http://dx.doi.org/10.3389/fimmu.2025.1636575 | DOI Listing |
Mol Clin Oncol
November 2025
Department of Obstetrics and Gynecology, Tokyo Women's Medical University, Tokyo 162-8666, Japan.
Uterine cervical lymphoepithelioma-like carcinoma (LELC) is a rare type of cervical squamous cell carcinoma (SCC). The present study describes a case of cervical LELC, including the cytological findings. A Japanese woman in her 40s was diagnosed with a high-grade squamous intraepithelial lesion (HSIL), suspected cytologically.
View Article and Find Full Text PDFFront Oncol
August 2025
Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Background: Primary pulmonary lymphoepithelioma-like carcinoma (pLELC) is a rare subtype of non-small cell lung cancer(NSCLC) with unclear etiological mechanisms. This study aimed to investigate the underlying molecular mechanisms and therapeutic targets for pLELC.
Methods: Retrospectively collected samples from advanced pLELC patients underwent proteomic and metabolomic analyses, and patient-derived xenograft (PDX) models were established for validation.
Case Rep Pathol
August 2025
Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, USA.
Lymphoepithelioma-like urothelial carcinoma (LELUC) and plasmacytoid urothelial carcinoma (PUC) are rare subtypes. We report a case of simultaneous urothelial carcinoma composed of LELUC and PUC subtypes, along with prostatic adenocarcinoma, with successful clinical management by immunotherapy. The patient, a 54-year-old man with a 40 pack-year smoking history, presented with gross hematuria and dysuria.
View Article and Find Full Text PDFCureus
August 2025
Department of Chest Surgery, Shimonoseki City Hospital, Yamaguchi, JPN.
The etiology of pulmonary lymphoepithelioma-like carcinoma (PLELC) remains unclear. We report the case of an 83-year-old man with a history of smoking who presented without any significant complaints. Computed tomography (CT) performed to investigate emphysema revealed a nodular shadow in the left upper lobe.
View Article and Find Full Text PDFFront Oncol
August 2025
Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy.
Lymphoepithelioma-like cholangiocarcinoma (LEL-CC) is a rare variant of cholangiocarcinoma characterized by undifferentiated malignant epithelial cells and a significant lymphoid infiltrate. Due to its rarity, there is currently no established treatment protocol for LEL-CC, and limited data are available regarding the genomic landscape of this rare tumor. In this report, we present the case of an 84-year-old woman with a history of Hepatitis C-related cirrhosis who was diagnosed with EBV-negative LEL-CC.
View Article and Find Full Text PDF